tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rigel Pharmaceuticals raises FY25 revenue view to $270M-$280M from $200M-$210M

Consensus is for FY25 revenue $223.42M. Raises FY25 net product sales view to $210M-$220M, from $185M-$192M; and contract revenues from collaborations $60M from the previous range of $15M-$18M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1